Indaptus Therapeutics
Price & Volume
Stats
See more52W Range | $1.51-$19.91 |
Market Cap | $3.9M |
Shares Short | 70,403 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$21.58 |
News
See moreYahoo Finance • 4 months ago
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
Yahoo Finance • 6 months ago
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
Yahoo Finance • 8 months ago
Indaptus Therapeutics Provides Clinical Update
Yahoo Finance • 9 months ago
Indaptus Therapeutics GAAP EPS of -$9.09
About
CEO | Mr. Junyi Dai |
Address | Three Columbus Circle, New York, NY, United States, 10019 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |